CAD 0.57
(7.55%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 68.14 Million USD | 8.55% |
2022 | 62.78 Million USD | 37.71% |
2021 | 45.59 Million USD | -31.81% |
2020 | 66.85 Million CAD | 158.08% |
2019 | 25.9 Million CAD | 68.34% |
2018 | 15.38 Million CAD | 1028.06% |
2017 | 1.36 Million CAD | 0.0% |
2016 | - CAD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 66.57 Million USD | -2.3% |
2024 Q2 | 51 Million USD | -23.39% |
2023 FY | 68.14 Million USD | 8.55% |
2023 Q4 | 68.14 Million USD | -12.19% |
2023 Q3 | 77.6 Million USD | 8.58% |
2023 Q2 | 71.47 Million USD | 3.94% |
2023 Q1 | 68.76 Million USD | 9.53% |
2022 Q3 | 67.86 Million CAD | -3.24% |
2022 Q2 | 70.13 Million CAD | -12.34% |
2022 Q1 | 80.01 Million CAD | 49.67% |
2022 Q4 | 62.78 Million CAD | -7.49% |
2021 Q4 | 53.46 Million CAD | -49.6% |
2021 Q3 | 106.08 Million CAD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aurora Cannabis Inc. | 186.37 Million CAD | 63.435% |
Avicanna Inc. | 4.54 Million CAD | -1399.684% |
Avant Brands Inc. | 28.93 Million CAD | -135.509% |
Cardiol Therapeutics Inc. | -279.87 Thousand CAD | 24450.133% |
Crescita Therapeutics Inc. | 6.12 Million CAD | -1012.64% |
Knight Therapeutics Inc. | 91.83 Million CAD | 25.791% |
MediPharm Labs Corp. | 9.89 Million CAD | -588.445% |
OrganiGram Holdings Inc. | 80.95 Million CAD | 15.816% |
Canopy Growth Corporation | 77.29 Million CAD | 11.829% |
Willow Biosciences Inc. | 221 Thousand CAD | -30736.743% |
Auxly Cannabis Group Inc. | 31.42 Million CAD | -116.835% |